2019: Articles in Press
Case Report

Rifampicin Induced Immune Hemolytic Anemia: A Case Report

Balaji Ommurugan
Drug Safety Physician, Pharmacovigilance, Bioclinica Private Limited, India
Kavitha Saravu
Professor, Department of Internal Medicine, KMC, MAHE, India.
Published February 5, 2019
  • Tuberculosis,
  • Rifampicin,
  • Hemolytic anemia,
  • Naranjo’s scaling



 Tuberculosis is usually treated with multiple drugs and these drugs are known to cause various side effects like hepatic abnormality, skin rashes, peripheral neuropathy, and vision disturbances. Autoimmune hemolytic anemia is very rare with antituberculosis drugs with only fifteen cases reported till date worldwide. Hence, we report a case of Rifampicin induced autoimmune hemolytic anemia in a patient, a known case of Gilbert’s syndrome from a tertiary care hospital in Southern India.